How actuaries can forecast the utilization of new technologies on the market
Policymakers would be wise to let the ACA fully develop before making substantial changes
Understanding a global health crisis from the confines of home
It’s time to talk about updating the HRBC formula to reflect the nature of the risks facing today’s health insurers
Actuarial expertise is informing clinical decision-making and health care cost-impact modeling
Initiative 18|11 explores prescription drug rebates and their impact on consumer pharmacy spend
Actuaries should account for the impact of coupons and PAPs on the health care system
Health actuaries should consider DTCPA impact when developing cost projections and setting premium rates